Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 2 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Amylyx Pharmaceuticals Inc | AMLX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.71 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.71 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 2 | 2 | - | 1.65 - 25.605 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:18:13 | 1 | $ 1.73 | USD |
Amylyx Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 115.91M | 67.78M | - | 380.79M | 49.27M | 0.73 | 2.35 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Amylyx Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMLX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.76 | 1.80 | 1.6795 | 1.75 | 1,064,273 | -0.05 | -2.84% |
| 1 Month | 1.83 | 1.90 | 1.65 | 1.75 | 1,145,844 | -0.12 | -6.56% |
| 3 Months | 3.03 | 3.03 | 1.65 | 2.13 | 1,815,437 | -1.32 | -43.56% |
| 6 Months | 14.52 | 19.9488 | 1.65 | 6.18 | 2,299,196 | -12.81 | -88.22% |
| 1 Year | 24.75 | 25.605 | 1.65 | 10.72 | 1,832,816 | -23.04 | -93.09% |
| 3 Years | 21.00 | 41.9297 | 1.65 | 17.45 | 1,319,746 | -19.29 | -91.86% |
| 5 Years | 21.00 | 41.9297 | 1.65 | 17.45 | 1,319,746 | -19.29 | -91.86% |
Amylyx Pharmaceuticals Description
| Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. |
